articleNew England Journal of MedicineJun 27, 2012Closed access

Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis

Rigshospitalet · Copenhagen University Hospital · +9 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis.

Methods

In this multicenter, parallel-group, blinded trial, we randomly assigned patients with severe sepsis to fluid resuscitation in the ICU with either 6% HES 130/0.42 (Tetraspan) or Ringer's acetate at a dose of up to 33 ml per kilogram of ideal body weight per day. The primary outcome measure was either death or end-stage kidney failure (dependence on dialysis) at 90 days after randomization.

Citation impact

1,826
total citations
FWCI
123.52
Percentile
100%
References
34
Citations per year

Authors

32

Topics & keywords

Keywords
  • Hydroxyethyl starch
  • Sepsis
  • Ringer's solution
  • Starch
  • Chemistry
  • Anesthesia
  • Medicine
  • Biochemistry
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.